MindMap Gallery Pharmacotherapy of Hypertension (Chi tiết)
Sơ đồ tư duy này cung cấp một cái nhìn tổng quan chi tiết về điều trị tăng huyết áp bằng thuốc, bao gồm các yếu tố quyết định sự kháng thuốc, quản lý dược lý, và các loại thuốc chẹn kênh canxi, thuốc lợi tiểu, và thuốc ức chế men chuyển. Mỗi phần được phân tích chi tiết với cơ chế hoạt động, ví dụ về thuốc, và tác dụng phụ. Ngoài ra, sơ đồ còn đề cập đến các biện pháp không dùng thuốc trong điều trị tăng huyết áp, giúp hiểu rõ hơn về cách kiểm soát huyết áp một cách toàn diện.
Edited at 2025-10-10 04:06:21This mind map provides a detailed overview of the pharmacotherapy for heart failure, focusing on drug categories, their mechanisms of action, and specific treatment strategies. It includes information on drugs used to manage heart failure symptoms and improve patient outcomes, such as ACE inhibitors, beta-blockers, diuretics, and newer pharmacological agents. The map also outlines treatment goals, non-pharmacological interventions, and considerations for different stages of heart failure, offering a comprehensive guide for healthcare professionals.
This mind map, created using EdrawMind, provides a detailed overview of anti-arrhythmic drugs. It categorizes the drugs into different classes based on their mechanisms of action, such as sodium channel blockers, beta-blockers, potassium channel blockers, and calcium channel blockers. Each category includes specific drugs, their mechanisms, clinical uses, and potential side effects. The mind map also features an overview section with an ECG waveform illustration, highlighting the effects of these drugs on heart rhythms, and an information section discussing general principles of arrhythmia treatment.
This mind map, created using EdrawMind, outlines the pharmacotherapy options for angina pectoris. It covers various classes of drugs used in treatment, including their mechanisms of action, therapeutic uses, and important considerations. The map is divided into sections such as "Angina," "Drugs," "Organic Nitrates," and "Management," providing a structured overview of how different medications alleviate symptoms and improve patient outcomes in angina pectoris.
This mind map provides a detailed overview of the pharmacotherapy for heart failure, focusing on drug categories, their mechanisms of action, and specific treatment strategies. It includes information on drugs used to manage heart failure symptoms and improve patient outcomes, such as ACE inhibitors, beta-blockers, diuretics, and newer pharmacological agents. The map also outlines treatment goals, non-pharmacological interventions, and considerations for different stages of heart failure, offering a comprehensive guide for healthcare professionals.
This mind map, created using EdrawMind, provides a detailed overview of anti-arrhythmic drugs. It categorizes the drugs into different classes based on their mechanisms of action, such as sodium channel blockers, beta-blockers, potassium channel blockers, and calcium channel blockers. Each category includes specific drugs, their mechanisms, clinical uses, and potential side effects. The mind map also features an overview section with an ECG waveform illustration, highlighting the effects of these drugs on heart rhythms, and an information section discussing general principles of arrhythmia treatment.
This mind map, created using EdrawMind, outlines the pharmacotherapy options for angina pectoris. It covers various classes of drugs used in treatment, including their mechanisms of action, therapeutic uses, and important considerations. The map is divided into sections such as "Angina," "Drugs," "Organic Nitrates," and "Management," providing a structured overview of how different medications alleviate symptoms and improve patient outcomes in angina pectoris.
Pharmacotherapy of hypertension
Introduction
Hypertension
Hyper - "high" ; tension - "pressure"
Blood pressure
Systolic: Ventricles of the heart contract and eject blood, pressure created in the arteries
Diastolic: Ventricles relax and heart temporarily stops ejecting blood, pressure in the arteries will fall
Pressure
Arterial - Greater than 110mmHg
Systolic - Greater than 135-140mmHg
Diastolic - Greater than 90mmHg
Types
Primary
Factors: Diet, obesity, age, race, heredity
Controlled by restricting salt, losing weight, stopping smoking
Secondary
Identifiable disorders: excessive renin secretion by the kidneys, arteriosclerosis and endocrine disorders (Cushing Syndrome and hyperthyroidism)
Treatment: Directed towards correcting the causative problem
Malignant
Develop quickly and reaches critical levels that can trigger complications (cerebral edema)
BP greater than 180/110mmHg, signs such as papilloedema and/or retinal hemorrhage
Effect
Brain
Blood clot resulting into stroke
Kidneys
Damage arteries can lead to kidney failure
Sexual organs
Sexual dysfunction due to decreased blood flow
Eyes
Blurred vision or ever vision loss
Heart
Hypertension forces heart to pump blood more forcefully through tight arteries, result: heart failure
Bones
Risk factor for bone loss or oesteoporosis
Baroreceptor
Definition
Specialized nerve endings
Detect changes in blood pressure
Non-capsulated nerve ending that are stimulated when stretched
Located in blood vessel walls
Function
Regulation of blood pressure
Senses stretch in vessel walls
Sends signals to the brain
Reflex actions
Changes heart rate
Adjusts blood vessel diameter
Types
Highpressure baroreceptors
Found in carotid sinus
Found in aortic arch
Lowpressure baroreceptors
Located in vena cavae
Monitors blood volume changes
Mechanism
Stretchinduced activation
Increased blood pressure stretches receptor
Triggers electrical signals
CNS processing
Signals relayed to medulla oblongata
Modulates autonomic nervous system
Clinical significance
Blood pressure disorders
Hypertension
Hypotension
Baroreflex dysfunction
Affects cardiovascular stability
May lead to syncope or fainting
Research and developments
Advances in baroreceptor studies
Understanding receptor pathways
Comparison across species
Potential therapies
Baroreceptor activation therapies
Device implantation for chronic conditions
Mechanism of controlling blood pressure
Baroreflexes mediated by sympathetic nervous system
1 An increase in arterial pressure stretches the baroreceptors in the carotid and aortic arch
2 Impulses from carotid sinus send to vasomotor centers through vagus nerves
3 If these receptors are stimulated by increase of blood pressure then they can cause vasodilation & a decrease in heart rate
4 If stimulated due to fall in BP the opposite result will occur
Baro-reflex
A fall in BP causes stimulation of pressure sensitive baroreceptors
Signal to
Cardiovascular centers in spinal cord
Reflex response to increase sympathetic and decrease parasympathetic output to the heart and vessels
Resulting in vasoconstriction, increase in Total Peripheral Resistance (TPR), increase in cardiac output and increase in BP
Renin - angiotensin - aldosterone system
Non-pharmacological Management of Hypertension
Aerobic exercise training
Resistance of exercise training
Weight loss
Healthy diet
Reduced sodium intake
Moderation in alcohol consumtion
Determinants of resistance
Blood viscosity
The higher the viscosity, the higher the resistance
Directly proportional
Hematocrit (the volume of red blood cells in the blood) is the primary determinant of blood viscosity
Vessel length
The longer the vessel length, the higher the resistance
Directly proportional
Blood will encounter greater friction
Vessel radius
The bigger the vessel radius, the lower the resistance
Indirectly proportional
Radius decreases, resistance increases exponentially by the fourth power
Pharmacological management
Angiotensin-Converting Enzyme (ACE) Inhibitors
Block the action of angiotensin-converting enzyme, reducing production of angiotensin II (narrows blood vessels)
Common ACE inhibitors: Enalapril, lisonapril, ramipril
Angiotension II Receptor Blockers (ARBs)
Blocking the action of angiotensin II at receptor sites, leading to blood vessel dilation
Common ARBs: Losartan, Valsartan, Irbesartan
Calcium Channel Blockers (CCBs)
Inhibit the entry of calcium into heart and blood vessel muscle cells, leading to relaxation and dilatation of blood vessels
Common CCBs: Amlodipine, Nifedipine, Verapamil
Diuretics
Help remove excess salt and water from the body, which can lower blood pressure
Common diuretic: Hydrochlorothiazide
Beta-blockers
Reduce heart rate and the force of contraction, leading to decreased blood pressure
Common beta-blockers: Metoprolol, atenolol, propranolol
Alpha-blockers
Alpha-blockers relax certain muscles and help dilate blood vessels, reducing blood pressure
Ex: Doxazosin
Central sympatholytics
Direct renin inhibitors
Regulating blood pressure
Ex: Aliskiren
Combination therapy
Antihypertensives
Vasolidators
Sympathetic inhibitors
Increased vascular resistance
Increased cardiac output
Increased venous return
Diuretics
Increased blood volume
Renin-angiotensin blockers
Drugs the alter sodium and water balance
Classes
Potassium sparing diuretics (PSD)
Sodium channel inhibition
Inhibiting sodium channels on the distal part of the nephron, distal tubule, and collecting ducts (place where sodium is reabsorbed)
When channels are blocked, the uptake of sodium is blocked and transepithelial potential is not generated; excretion of potassium is decrease
Aldosterone antagonism
Drug that inhibit aldosterone activity by binding to aldosterone receptors present on the collecting ducts
Decrease the reabsorption of sodium and water
Loop diuretics (LD)
Inhibit sodium-potassium-chloride symporter present in the thick ascending limb of the loop of Henle
Inhibit sodium reuptake
Thiazide diuretics (TD)
Control hypertension in part by inhibiting reabsorption of sodium and chloride ions from convoluted tubules (kidneys) by blocking the thiazide-sensitive Na+-Cl- symporter
Function
Act on kidney to increase production of urine
Lower BP
1) Depleting body sodium stores
Blood volume reduced
Cardiac output reduced
2) Reduce peripheral resistance
Sodium contributes to vascular resistance
May be used as first line agents (Enhance efficacy of other antihypertensives)
TD appropriate for most mild/moderate cases (normal renal function)
LD for more severe cases, renal insufficiency and cardiac failure